Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Mandarin Oriental Washington D.C.

Jan 23, 2017 7:30 AM - Jan 25, 2017 3:15 PM

1330 Maryland Avenue, SW, Washington, DC 20024

Pharmacovigilance and Risk Management Strategies Conference

Session 10: Advanced Therapies

Session Chair(s)

Robert L. Levin, MD

Robert L. Levin, MD

Lead Medical Officer for Pharmacovigilance Strategy

FDA, United States

Session Chair

Speaker(s)

James  Wabby, MHS

James Wabby, MHS

AbbVie, United States

Global Head, Regulatory Affairs, Emerging Technologies and Combination Products

Gerald L. Messerschmidt, MD, FACP

Precision Medicine, Pharmacovigilance, and Risk Management

Gerald L. Messerschmidt, MD, FACP

Precision Oncology, United States

Chief Medical Officer

Dina  Tresnan, DVM, PhD

Pharmacovigilance and Risk Management of Advanced Therapies

Dina Tresnan, DVM, PhD

Pfizer Inc, United States

SSRM Disease Area Cluster Lead - Oncology

Abla  Creasey, PhD

Safety Considerations for Regenerative Medicine

Abla Creasey, PhD

California Institute of Regenerative Medicine, United States

Vice President Therapeutics Development

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.